Search

everythinglearnresearchcommunity

for

Search:↓

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Finasteride causes abnormal growth in male mice cells at high doses.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Baldness score can't be used to predict prostate size.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.